Induction of prostate-specific antigen expression by synthetic progestins in patients with prostate and breast cancer [3] (multiple letters)

Mayo Clinic Proceedings

Volumn 73, Issue 7, 1998, Pages 706-707

  Diamandis, E P ^a   Akerley, W L ^a   Wehbe, T W ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; BREAST CANCER; HORMONAL REGULATION; HORMONE ACTION; HUMAN; LETTER; PROSTATE CANCER; PROTEIN INDUCTION;

EID: 0031782398     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(11)64903-3     Document Type: Letter

References (4)

1. NA Dawson DG McLeod Dramatic prostate specific antigen decrease in response to discontinuation of rnegestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome J Urol 153 1995 1946 1947
2. EP Dlamandls H Yu New biological functions of prostate-specific antigen? [editorial] J Clin Endocrinol Metab 80 1995 1515 1517
3. N Zarghaml L Grass EP Dlamandis Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer Br J Cancer 75 1997 579 588
4. Dlamandls EP, Helle SL, Yu H, Melegos DN, Lundgren S, Lonning PE. Prognostic value of plasma prostate specific antigen following rnegestrol acetate treatment in patients with metastatic breast cancer [submitted for publication]